Biofourmis Wins Two 2021 Fierce Healthcare Innovation Awards for Hospital@Home Solution

Comprehensive, turnkey platform that delivers inpatient-level care at home earns recognition for “Digital/Mobile Health Solution” and “Best in Show: Cost Saving”

BOSTON, December 13, 2021 Biofourmis, a Boston-based global leader in digital medicine and virtual care that powers personalized predictive care, today announced that its Hospital@Home solution has been named by Fierce Healthcare as the Digital/Mobile Health Solution Winner and Best in Show Winner for Cost Saving in the Fierce Healthcare Innovation Awards 2021.

The awards program for this leading healthcare media outlet showcases outstanding innovations that are driving improvements and transforming the industry. The Fierce Innovation Award judges chose Hospital@Home as a winner based on its demonstrated potential to save money, engage patients and/or revolutionize the healthcare industry.

Hospital@Home is an end-to-end, turnkey solution that includes an artificial-intelligence-based platform, medical-grade wearable biosensor and patient and clinician apps, all seamlessly integrated with capabilities such as telehealth and video conferencing. The solution was co-developed with Brigham and Women’s Hospital, a Harvard Medical School teaching hospital, and is in use in health systems across the world.

Hospital@Home also includes both active and continuous passive data collection of more than 20 physiological parameters on an ongoing basis. The platform’s artificial intelligence (AI)-based analytics notifies clinicians of any decompensation early on, so that the clinician can intervene and prevent a medical crisis. The AI-powered Biovitals® Analytics Engine inside Hospital@Home has been used to remotely monitor more than 100,000 patients globally.

“It is an honor to receive multiple awards in such a prestigious awards competition alongside the other leading digital health and virtual care companies around the world who have recognized that the future of healthcare is in the patient’s home, whether that is for a hospital stay, post-acute care or chronic condition management,” said Kuldeep Singh Rajput, CEO and founder of Biofourmis. “We are grateful that Fierce Healthcare has made this annual event possible so that more providers can learn about the vetted and proven solutions that can help their organizations thrive during this exciting new era of healthcare.”

Rebecca Willumson, Vice President & Publisher, Fierce Life Sciences & Healthcare said, “The awards program was designed to showcase innovative solutions from our industry over the past year. We received a tremendous amount of nominations and our panel of judges looked for effectiveness, technical innovation, competitive advantage, financial impact and true innovation. We believe the winners of the 2021 program have the greatest potential to save money, engage patients or revolutionize the industry. Congratulations to all of the Innovation Award winners.”

About Biofourmis

Biofourmis is a global leader in virtual care and digital medicine, offering innovative solutions that enable clinicians to deliver personalized predictive care anywhere. Biovitals®, a highly sophisticated AI-powered health analytics engine, utilizes medical-grade wearables to continuously collect patient data targeted to predict clinical exacerbation in advance of a critical event, which enables earlier interventions and can lead to better outcomes. The Biovitals analytics engine has been clinically validated across multiple medicine areas for acute and chronic conditions, oncology, infectious disease such as COVID-19, chronic pain, and COPD, and is prescribed as a companion digital medicine with pharmacotherapy in value-based care.

For more information, visit:

Media Contact:

Tara Stultz

Amendola Communications for Biofourmis


Additional Readings:

Biofourmis Names New CFO to Help Drive the Digital medicine Start-Up’s Growth Plans 

Partnership with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model 

Digital medicine Leader to Take Part in Pioneering Heart Failure Research with Yale University-Mayo Clinic Center